{"id":2638,"date":"2019-10-23T15:33:27","date_gmt":"2019-10-23T19:33:27","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/opioid-settlement-and-teva-pharmaceutical-industries\/"},"modified":"2022-06-27T02:34:10","modified_gmt":"2022-06-27T06:34:10","slug":"osiedle-opioidow-i-teva-przemysl-farmaceutyczny","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/biale-papiery\/osiedle-opioidow-i-teva-przemysl-farmaceutyczny\/","title":{"rendered":"Opioid Settlement i Teva Pharmaceutical Industries"},"content":{"rendered":"<p><strong>Jakie leki produkuje Teva?\u00a0<\/strong><\/p>\n<p>It specializes primarily in generic drugs. Some of the opioid drugs include oxycodone and fentanyl, which is a synthetic opiate. Another\u00a0is oxymorphone.<\/p>\n<p>Terms of a\u00a0deal involving McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp. and Teva Pharmaceutical Industries Ltd. were expected to be announced later in the day. Cuyahoga County lawyer Hunter Shkolnik says the settlement amounts to $260 million.<\/p>\n<p>The Ohio case had been slated to be the first federal trial related to an\u00a0opioid crisis that has claimed an estimated 400,000 American lives\u00a0over two decades.<\/p>","protected":false},"excerpt":{"rendered":"<p>Jakie leki produkuje Teva? Specjalizuje si\u0119 przede wszystkim w lekach generycznych. Niekt\u00f3re leki opioidowe obejmuj\u0105 oksykodon i fentanyl, kt\u00f3ry jest syntetycznym opiatem. Innym jest oksymorfon. Warunki umowy\u2026<\/p>","protected":false},"featured_media":0,"menu_order":245,"template":"","whitepaper_category":[57,75,98,253,254],"whitepaper-source":[271],"class_list":["post-2638","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-hunter-shkolnik","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-usa-today-network"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2638\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=2638"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper_category?post=2638"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper-source?post=2638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}